Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

The Safety and Efficacy of Chronic Weekly Rozanolixizumab Treatment in Patients with Generalized Myasthenia Gravis (MG0004)

Author:Bril, Vera   Druzdz, Artur   Grosskreutz, Julian   Habib, Ali A.   Kaminski, Henry J.   Mantegazza, Renato   Sacconi, Sabrina   Utsugisawa, Kimiaki   Vu, Tuan   Boehnlein, Marion   Woltering, Franz   Greve, Bernhard   Gayfieva, Maryam   Vissing, John   

Session Name:P4: Autoimmune Neurology: Peripheral Autoimmunity  

Topic:Autoimmune Neurology  

Program Number:P4.017  

Author Institution:University Health Network, Toronto, ON, Canada, Toronto, ON, Canada  Department of Neurology, Municipal Hospital, Poznan, Poland, Swarzedz, Poland  Precision Neurology, Department of Neurology, University of Lübeck, Lübeck, Germany, Lubeck, Germany  MDA ALS and Neuromuscular Center, University of California, Irvine, Irvine, CA, USA, Orange, CA  Department of Neurology & Rehabilitation Medicine, George Washington University, Washington, DC, USA, Washington, DC  Department of Neuroimmunology and Neuromuscular Diseases, Fondazione IRCCS, Istituto Nazionale Neurologico Carlo Besta, Milan, Italy, Milan, Italy  Université Côte d’Azur, Peripheral Nervous System & Muscle Department, Pasteur 2 Hospital, Centre Hospitalier Universitaire de Nice, Nice, France, Nice, France  Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan, Hanamaki, Japan  Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, USA, Tampa, FL  UCB Pharma, Monheim, Germany, Monheim, Germany  UCB Pharma, Monheim, Germany, Monheim Am Rhein, Germany  UCB Pharma, Slough, UK, London, United Kingdom  Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, Copenhagen, Denmark  

CARDINALS: A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Utreloxastat (PTC857) in Patients with Amyotrophic Lateral Sclerosis

Author:Katz, Jonathan S   Vu, Tuan   Chio, Adriano   McDermott, Christopher   Devos, David   Johnston, Mayzie   Sierra, Rafael   Tansy, Aaron   Trimmer, Jeff   Shefner, Jeremy M   

Session Name:P5: Neuromuscular and Clinical Neurophysiology (EMG): Amyotrophic Lateral Sclerosis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P5.010  

Author Institution:Forbes Norris MDA/ALS Research and Treatment Center, San Francisco, CA  University of South Florida, Tampa, FL  Dept. of Neuroscience, University of Turin, Torino, Italy  Department of Neuroscience, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, United Kingdom  Service De Neurologie Du Pr. Desteee, Lille, France  PTC Therapeutics, Inc, South Plainfield, NJ  Barrow Neurological Institute, University of Arizona, Phoenix, AZ  

Drivers of New Rozanolixizumab Treatment Cycles in Patients with Generalized Myasthenia Gravis in the Phase 3 MycarinG and Open-label Extension Studies

Author:Mahuwala, Zabeen K.   Grosskreutz, Julian   Habib, Ali A.   Mantegazza, Renato   Pascuzzi, Robert M.   Sacconi, Sabrina   Vissing, John   Vu, Tuan   Beau-Lejdstrom, Raphaelle   Greve, Bernhard   Grimson, Fiona   Tarancón, Thaïs   Bril, Vera   

Session Name:P10: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P10.003  

Author Institution:Department of Neuromuscular Medicine, Epilepsy and Clinical Neurophysiology, University of Kentucky, Lexington, KY, USA, LEXINGTON, KY  Precision Neurology, Department of Neurology, University of Lübeck, Lübeck, Germany, Lübeck, Germany  MDA ALS and Neuromuscular Center, University of California, Irvine, Irvine, CA, USA, Orange, CA  Department of Neuroimmunology and Neuromuscular Diseases, Fondazione IRCCS, Istituto Nazionale Neurologico Carlo Besta, Milan, Italy, Milan, Italy  Neurology Department, Indiana University School of Medicine, Indiana University Health, Indianapolis, IN, USA, Indianapolis, IN  Université Côte d'Azur, Peripheral Nervous System & Muscle Department, Pasteur 2 Hospital, Centre Hospitalier Universitaire de Nice, Nice, France, Nice, France  Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, Copenhagen, Denmark  Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, USA, Tampa, FL  UCB Pharma, Bulle, Switzerland, Bulle, Switzerland  UCB Pharma, Monheim, Germany, Monheim, Germany  UCB Pharma, Slough, UK, London, United Kingdom  UCB Pharma, Madrid, Spain, Madrid, Spain  University Health Network, Toronto, ON, Canada, Toronto, ON, Canada  

Response to Rozanolixizumab Across Treatment Cycles in Patients with Generalized Myasthenia Gravis: A Post-hoc Analysis

Author:Pascuzzi, Robert M.   Grosskreutz, Julian   Habib, Ali A.   Mahuwala, Zabeen K.   Mantegazza, Renato   Sacconi, Sabrina   Vissing, John   Vu, Tuan   Beau Lejdstrom, Rapha?lle   Greve, Bernhard   Grimson, Fiona   Tarancón, Thaïs   Bril, Vera   

Session Name:P10: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P10.005  

Author Institution:Neurology Department, Indiana University School of Medicine, Indiana University Health, Indianapolis, IN, USA, Indianapolis, IN  Precision Neurology, Department of Neurology, University of Lübeck, Lübeck, Germany, Lübeck, Germany  MDA ALS and Neuromuscular Center, University of California, Irvine, Irvine, CA, USA, Orange, CA  Department of Neuromuscular Medicine and Clinical Neurophysiology, University of Kentucky, Lexington, KY, USA, Lexington, KY  Department of Neuroimmunology and Neuromuscular Diseases, Fondazione IRCCS, Istituto Nazionale Neurologico Carlo Besta, Milan, Italy, Milan, Italy  Université Côte d'Azur, Peripheral Nervous System & Muscle Department, Pasteur 2 Hospital, Centre Hospitalier Universitaire de Nice, Nice, France, Nice, France  Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, Copenhagen, Denmark  Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, USA, Tampa, FL  UCB Pharma, Bulle, Switzerland, Bulle, Switzerland  UCB Pharma, Monheim, Germany, Monheim, Germany  UCB Pharma, Slough, UK, Slough, United Kingdom  UCB Pharma, Madrid, Spain, Madrid, Spain  University Health Network, Toronto, ON, Canada, Toronto, ON, Canada  

Long-term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Participants with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC+ Study

Author:Howard, James   Li, Yuebing   Vu, Tuan   Korobko, Denis   Steeland, Sophie   Van Hoorick, Benjamin   Podhorna, Jana   Hodari, Moana   Utsugisawa, Kimiaki   Sacca, Francesco   Wiendl, Heinz   De Bleecker, Jan   Mantegazza, Renato   

Session Name:P10: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P10.008  

Author Institution:Department of Neurology, The University of North Carolina, Chapel Hill, North Carolina, Chapel Hill, NC  Cleveland Clinic, Cleveland, Ohio, Cleveland, OH  Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, Florida, Tampa, FL  State Budgetary Healthcare Institution of Novosibirsk Region "State Novosibirsk Regional Clinical Hospital," Novosibirsk, Russia, Novosibirsk, Russian Federation  argenx, Ghent, Belgium, Ghent, Belgium  argenx, Ghent, Belgium, Ghent , Belgium  argenx, Ghent, Belgium, Wiesbaden, Germany  argenx, Ghent, Belgium, Camberley, United Kingdom  Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan, Hanamaki, Japan  NRSO Department, Federico II University of Naples, Naples, Italy, Napoli, Italy  Department of Neurology, University of Münster, Münster, Germany, Muenster, Germany  Ghent University Hospital, Ghent, Belgium , Gent, Belgium  Department of Neuroimmunology and Neuromuscular Diseases, Fondazione Istituto Neurologico Carlo Besta, Milan, Italy, Milan, Italy